Peter Hjorth1, Reinhold Kilian2, Helle Østermark Sørensen3, Susan Engelbrechsen Eriksen4, Annette Sofie Davidsen5, Signe Olrik Wallenstein Jensen3, Povl Munk-Jørgensen6. 1. Aarhus University Hospital - Randers Lokal Psychiatry, Dronningborg Boulevard 15, Randers, 8900, Denmark. 2. Klinik fur Psyckiatrie und Psychotherapie, Ulm University, Gunzburg, Germany. 3. Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aalborg, Denmark. 4. Region of North Jutland - Visborggaard, Visborg, Denmark. 5. Institut for folkevidenskab, Copenhagen University - Forskningsenheden for Almen Praksis og Afdelingen for Almen Medicin, Copenhagen, Denmark. 6. Aarhus University Hospital, Risskov - M, Aarhus, Denmark.
Abstract
BACKGROUND: Many patients with mental illness receivepsychotropic medicine in high dosages and from more than one drug. One of the consequences of this practice is obesity, which is a contributing factor to increased physical morbidity and premature death. METHODS: Our study was a cluster-randomized intervention study involving 6 facilities and 174 patients diagnosed with severe mental illnesses (73% schizophrenia). The intervention period was 12 months and consisted of teaching sessions with the staff and evaluating the patients' intake of psychotropic medication. At index, 44% met criteria for obesity and 76% met criteria for overweight. Waist circumferences were 108 cm for men and 108 cm for women. Olanzapine, clozapine and quetiapine were the most common prescribed antipsychotics. Mean values of daily doses of antipsychotic were 2.5. RESULTS: The intervention showed no significant differences between the intervention and control group regarding psychotropic treatment. At follow up, independent of intervention, patients receiving antipsychotic polypharmacy had a larger waist circumference compared with patients receiving antipsychotic monotherapy of 9.8 cm (1.5-18.1) (p = 0.028). DISCUSSION AND CONCLUSION: We found both a high prevalence of obesity and that the patients received treatment with antipsychotic polypharmaceutics in high dosages. Active awareness did not change practice and we must think of other ways to restrict treatment with psychotropics in this group of patients.
RCT Entities:
BACKGROUND: Many patients with mental illness receive psychotropic medicine in high dosages and from more than one drug. One of the consequences of this practice is obesity, which is a contributing factor to increased physical morbidity and premature death. METHODS: Our study was a cluster-randomized intervention study involving 6 facilities and 174 patients diagnosed with severe mental illnesses (73% schizophrenia). The intervention period was 12 months and consisted of teaching sessions with the staff and evaluating the patients' intake of psychotropic medication. At index, 44% met criteria for obesity and 76% met criteria for overweight. Waist circumferences were 108 cm for men and 108 cm for women. Olanzapine, clozapine and quetiapine were the most common prescribed antipsychotics. Mean values of daily doses of antipsychotic were 2.5. RESULTS: The intervention showed no significant differences between the intervention and control group regarding psychotropic treatment. At follow up, independent of intervention, patients receiving antipsychotic polypharmacy had a larger waist circumference compared with patients receiving antipsychotic monotherapy of 9.8 cm (1.5-18.1) (p = 0.028). DISCUSSION AND CONCLUSION: We found both a high prevalence of obesity and that the patients received treatment with antipsychotic polypharmaceutics in high dosages. Active awareness did not change practice and we must think of other ways to restrict treatment with psychotropics in this group of patients.
Authors: Y-T Xiang; C-Y Wang; T-M Si; E H M Lee; Y-L He; G S Ungvari; H F K Chiu; S-Y Yang; M-Y Chong; C-H Tan; E-H Kua; S Fujii; K Sim; K H Yong; J K Trivedi; E-K Chung; P Udomratn; K-Y Chee; N Sartorius; N Shinfuku Journal: Pharmacopsychiatry Date: 2011-10-11 Impact factor: 5.788
Authors: Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl Journal: Schizophr Bull Date: 2009-12-02 Impact factor: 9.306
Authors: Baojin Zhu; Haya Ascher-Svanum; Douglas E Faries; Christoph U Correll; John M Kane Journal: BMC Psychiatry Date: 2008-04-04 Impact factor: 3.630